Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
National Institutes of Health Clinical Center (CC)
University Hospital, Tours
Hôpital du Valais
National Cancer Institute (NCI)
Hunan Province Tumor Hospital
Hunan Province Tumor Hospital
Guangdong Provincial People's Hospital
Shanghai JMT-Bio Inc.
University of Washington
Shanghai Pulmonary Hospital, Shanghai, China
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tang-Du Hospital
AstraZeneca
iLeukon Therapeutics, Inc.
Novartis
Sun Yat-sen University
Hansoh BioMedical R&D Company
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
EpiBiologics
Qilu Pharmaceutical Co., Ltd.
Peking University Cancer Hospital & Institute
University Health Network, Toronto
University Health Network, Toronto
CSPC Megalith Biopharmaceutical Co.,Ltd.
Henry Ford Health System
Suzhou BlueHorse Therapeutics Co., Ltd.
Aarhus University Hospital
National Taiwan University Hospital
Chong Kun Dang Pharmaceutical
Cancer Research UK
Radiopharm Theranostics, Ltd
Merck Sharp & Dohme LLC
Samsung Medical Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
RemeGen Co., Ltd.
IntoCell, Inc
Bristol-Myers Squibb
Bristol-Myers Squibb
Roswell Park Cancer Institute
MediLink Therapeutics (Suzhou) Co., Ltd.
Fudan University
Fudan University
Dana-Farber Cancer Institute
Guangdong Association of Clinical Trials
AstraZeneca
Regeneron Pharmaceuticals
Hacettepe University